A new program in nutrigenomics has resulted from a partnership between researchers at the UA, researchers Adam P. Dicker and Susan Lanza – Jacoby at Thomas Jefferson University in Philadelphia and Marc S. Halfon at the University at Buffalo in New York.
CONTACT: Media, Julie Lux,+1-908-298-4774, or Investors, Janet Barth or Alex Kelly,+1-908-298-7436.. Coricidin HBP is a registered trademark of Schering Corporation, a subsidiary of Schering-Plough Corporation, Kenilworth, NJ Schering – Plough is a global science – based health care company with leading prescription, consumer and animal health. Discovered through internal research and collaboration with partners, Schering-Plough, develops, manufactures and markets advanced drug therapies to meet important medical needs.Michael Jennings by UQ for biological and chemical faculty.
####For further information please go to: The University of Queensland, Brisbane.. The Statistics indicate that by patients who began to Your the treatment in March 2007, 48 percent waited nor more than 18 weeks after the first referral from the GP – published improving snapshot of Facts in December 2006 that showed that between 35 percent of patients receiving treatment within 18 weeks.